MediciNova Inc (MNOV) stock
MNOVNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$1.34+0.00 (0.00%)
Close on Nov 17, 2026Market cap $65.96MP/E –Yield –
MediciNova operating margin
Operating margin is operating income as a percentage of revenue.
MediciNova's operating margin for the twelve months ending Jun 30, 2026 was -1287.4%. For fiscal 2025 it was -3242.5%, against -990.0% the year before. The highest annual figure on record is -253.0% in fiscal 2021.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -3242.5% | −2252.4 |
| FY2023 | Dec 31, 2023 | -990.0% | −737.0 |
| FY2021 | Dec 31, 2021 | -253.0% | +123190.0 |
| FY2013 | Dec 31, 2013 | -123443.0% | −122079.3 |
| FY2012 | Dec 31, 2012 | -1363.8% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -554.3% | +2125.6 |
| Q1 FY2026 | Mar 31, 2026 | -1516.6% | −1401.9 |
| Q4 FY2025 | Dec 31, 2025 | -2038.0% | +7567.2 |
| Q3 FY2025 | Sep 30, 2025 | -2741.7% | −2736.6 |
| Q2 FY2025 | Jun 30, 2025 | -2679.9% | – |
| Q3 FY2023 | Sep 30, 2023 | -114.7% | – |
| Q3 FY2021 | Sep 30, 2021 | -9605.2% | – |
| Q1 FY2021 | Mar 31, 2021 | -5.0% | – |
See a number that looks wrong?